Clouston Syndrome

Mendelian MONDO:0007510 Pathograph 10 Ectodermal Dysplasia Palmoplantar Keratoderma

Clouston syndrome (hidrotic ectodermal dysplasia, HED; OMIM 129500) is a rare autosomal dominant disorder caused by missense mutations in GJB6, encoding the gap junction protein connexin 30 (Cx30). It is characterized by the classic triad of nail dystrophy, alopecia, and palmoplantar keratoderma, with normal sweat gland function and dentition distinguishing it from anhidrotic/hypohidrotic ectodermal dysplasias. The disorder occurs worldwide at very low frequency (~1:100,000) but is enriched in French-Canadian populations due to a founder effect. Mutant Cx30 causes aberrant hemichannel activity and impaired gap junction communication in keratinocytes, hair follicles, and nail matrix.

Ask OpenScientist

Ask a research question about Clouston Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

5
Pathophys.
1
Histopath.
8
Phenotypes
10
Pathograph
1
Genes
5
Treatments
1
Deep Research
⚙

Pathophysiology

5
Aberrant Hemichannel Activity and ATP Release
The G11R and A88V mutations in Cx30 confer a gain of function, forming functional hemichannels at the cell surface that leak ATP into the extracellular medium. This aberrant paracrine signaling may alter the epidermal factors controlling keratinocyte proliferation and differentiation, contributing to the HED phenotype.
Keratinocyte link
Gap Junction Assembly link Epidermis Development link
Downstream
Impaired Epidermal Differentiation Aberrant ATP release from mutant hemichannels disrupts normal keratinocyte differentiation and desquamation.
Show evidence (1 reference)
PMID:15213106 SUPPORT In Vitro
"we document a gain of function of G11R and A88V Cx30, which form functional hemichannels at the cell surface and, when expressed in HeLa cells, generate a leakage of ATP into the extracellular medium"
Demonstrates that HED-causing Cx30 mutations gain hemichannel function, releasing ATP that may alter epidermal homeostasis.
Impaired Connexin 30 Trafficking
In the absence of wild-type Cx30, skin disease-associated Cx30 mutations show impaired trafficking to the plasma membrane, preventing formation of functional gap junctions. This loss-of-function mechanism reduces intercellular communication in keratinocytes, complementing the hemichannel gain-of-function mechanism.
Keratinocyte link
Gap Junction Assembly link
Downstream
Impaired Epidermal Differentiation Reduced gap junction-mediated intercellular communication contributes to impaired keratinocyte differentiation and hyperkeratosis.
Show evidence (1 reference)
PMID:12419304 SUPPORT In Vitro
"For all three of the skin disease-associated Cx30 mutations investigated, impaired trafficking of the protein to the plasma membrane was observed thus preventing the formation of functional Cx30 gap junctions"
Shows that skin disease-associated Cx30 mutations impair protein trafficking, preventing normal gap junction formation in keratinocytes.
Impaired Epidermal Differentiation
Dysfunctional gap junction communication in keratinocytes disrupts normal epidermal differentiation and desquamation. Reduced intercellular coupling combined with aberrant hemichannel-mediated ATP signaling leads to hyperkeratosis, particularly in the palmoplantar epidermis where Cx30 is normally highly expressed.
Keratinocyte link
Keratinocyte Differentiation link
Show evidence (2 references)
PMID:15213106 SUPPORT In Vitro
"Such increased ATP levels might act as a paracrine messenger that, by altering the epidermal factors which control the proliferation and differentiation of keratinocytes, may play an important role in the pathophysiological processes leading to the HED phenotype"
Proposes mechanism by which aberrant ATP release from mutant hemichannels disrupts keratinocyte differentiation.
PMID:25575739 SUPPORT Human Clinical
"Moderate to severe hyperkeratosis is often present, with reduced keratinocytes desquamation"
Clinical observation confirming impaired keratinocyte desquamation as part of the Clouston syndrome epidermal phenotype.
Hair Follicle Dysfunction
Connexin 30 is normally expressed in the inner root sheath and cortex of hair follicles. Mutations disrupt intercellular gap junction signaling in the hair follicle, leading to progressive alopecia. Hair is characteristically dry, fine, and brittle, and may be completely absent from the scalp, axillary, and pubic regions.
Hair Follicle Cell link
Hair Cycle link
Show evidence (2 references)
PMID:23219093 SUPPORT Human Clinical
"Immunostaining in normal human skin sections demonstrated predominant expression of Cx30 in hair follicles, nails, and palmoplantar epidermis"
Establishes that Cx30 is predominantly expressed in hair follicles, explaining why GJB6 mutations cause alopecia.
PMID:32843087 SUPPORT Human Clinical
"Skin biopsy of trunk showed hyperkeratosis with normal distribution of eccrine and sebaceous gland, but absence of hair follicles"
Histological finding showing complete absence of hair follicles in affected skin of a patient with the A88V mutation.
Nail Matrix Disruption
Dysfunctional gap junctions in the nail matrix impair normal nail plate formation. Nail dystrophy is often the earliest and most consistent feature, with nails becoming thick, hyperplastic, deformed, and showing onycholysis. Some patients show unusual pterygium formation and nail thinning.
Show evidence (1 reference)
PMID:25575739 SUPPORT Human Clinical
"nails are predominantly affected. They are thick, hyperplastic, and deformed with onycholysis"
Describes the characteristic nail pathology in Clouston syndrome as the predominant clinical feature.
✶

Histopathology

1
Absence of Hair Follicles with Preserved Eccrine Glands
Skin biopsy shows hyperkeratosis with absence of hair follicles but normal distribution of eccrine and sebaceous glands. This pattern distinguishes Clouston syndrome from anhidrotic ectodermal dysplasias.
Show evidence (1 reference)
PMID:32843087 SUPPORT Human Clinical
"Skin biopsy of trunk showed hyperkeratosis with normal distribution of eccrine and sebaceous gland, but absence of hair follicles"
Histopathological finding in an affected patient confirming the characteristic pattern of absent hair follicles with preserved glands.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Clouston Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

8
Ear 1
Sensorineural Hearing Loss OCCASIONAL Sensorineural hearing impairment (HP:0000407)
Show evidence (1 reference)
PMID:32843087 SUPPORT Human Clinical
"Only two patients have hearing disorders (the proband and her father)"
Reports sensorineural hearing loss in 2 of 24 affected family members with the A88V mutation, indicating low frequency.
Integument 3
Nail Dystrophy VERY_FREQUENT Nail dystrophy (HP:0008404)
Show evidence (3 references)
PMID:25575739 SUPPORT Human Clinical
"nails are predominantly affected. They are thick, hyperplastic, and deformed with onycholysis"
Describes nail dystrophy as the predominant clinical feature in Clouston syndrome.
PMID:32843087 SUPPORT Human Clinical
"Physical examination revealed that her fingernails and toenails are atrophic, short, thickened and brittle with pterygium formation"
Clinical description of nail changes in a Chinese patient with A88V mutation.
PMID:36645631 SUPPORT Human Clinical
"We identified a new clinical phenotype involving all nail needling pain in all patients"
Reports cold-triggered nail pain as a novel clinical feature in a G45A pedigree.
Alopecia VERY_FREQUENT Alopecia (HP:0001596)
Show evidence (2 references)
PMID:15213106 SUPPORT In Vitro
"Clouston syndrome or hidrotic ectodermal dysplasia (HED) is a rare dominant genodermatosis characterized by palmoplantar hyperkeratosis, generalized alopecia and nail defects"
Confirms generalized alopecia as a cardinal feature of Clouston syndrome.
PMID:25575739 SUPPORT Human Clinical
"Hair is dry, fine, and brittle, and may be absent from the scalp, axillary, and pubic region"
Clinical description of hair changes in Clouston syndrome.
Hyperpigmentation FREQUENT Hyperpigmentation of the skin (HP:0000953)
Show evidence (1 reference)
PMID:25575739 SUPPORT Human Clinical
"The skin of his palms and soles was hyperkeratotic and mildly hyperpigmented on the joints"
Clinical observation of hyperpigmentation over joints in an affected father with Clouston syndrome.
Other 4
Palmoplantar Keratoderma VERY_FREQUENT Diffuse palmoplantar hyperkeratosis (HP:0007447)
Show evidence (2 references)
PMID:15213106 SUPPORT In Vitro
"Clouston syndrome or hidrotic ectodermal dysplasia (HED) is a rare dominant genodermatosis characterized by palmoplantar hyperkeratosis, generalized alopecia and nail defects"
Identifies palmoplantar hyperkeratosis as one of the three cardinal features of Clouston syndrome.
PMID:25575739 SUPPORT Human Clinical
"Clouston syndrome is characterized by nail dystrophy, hypotrichosis, and palmoplantar keratoderma"
Confirms palmoplantar keratoderma as a core diagnostic feature of Clouston syndrome.
Follicular Hyperkeratosis FREQUENT Follicular hyperkeratosis (HP:0007502)
Show evidence (1 reference)
PMID:32843087 SUPPORT Human Clinical
"The skin all over her body is thickened and hyperkeratosis with dense follicular hyperkeratotic papules"
Reports follicular hyperkeratotic papules as a clinical feature in an affected Chinese patient.
Sparse Eyebrows FREQUENT Sparse eyebrow (HP:0045075)
Show evidence (1 reference)
PMID:25575739 SUPPORT Human Clinical
"sparse eyebrows and eyelashes"
Describes sparse eyebrows in a Clouston syndrome patient.
Sparse Eyelashes FREQUENT Sparse eyelashes (HP:0000653)
Show evidence (1 reference)
PMID:25575739 SUPPORT Human Clinical
"sparse eyebrows and eyelashes"
Describes sparse eyelashes in a Clouston syndrome patient.
🧬

Genetic Associations

1
GJB6 pathogenic variants
Autosomal dominant
Show evidence (4 references)
PMID:32843087 SUPPORT Human Clinical
"Four mutations (p.G11R, p.A88V, p.V37E and p.D50N) in gap junction beta 6 (GJB6) gene, which codes connexin30 protein, have been found to cause HED in different populations"
Establishes the four known pathogenic GJB6 mutations causing hidrotic ectodermal dysplasia across different populations.
PMID:25808784 SUPPORT Human Clinical
"Mutations in the GJB6 gene, which encodes the gap junction protein connexin 30, have been shown to cause this disorder. To date, four mutations of GJB6 have been found in patients with CS: G11R, V37E, D50N and A88V"
Confirms the four known GJB6 mutations and reports a novel fifth mutation (N14S) in a Chinese pedigree.
PMID:23219093 SUPPORT Human Clinical
"We identified a recurrent heterozygous mutation c.31G>C (p.Gly11Arg) in the GJB6 gene in the Lebanese-German family with Clouston syndrome"
Confirms G11R as a recurrent pathogenic mutation and demonstrates Cx30 expression in hair follicles, nails, and palmoplantar epidermis.
+ 1 more reference
💊

Treatments

5
Symptomatic Nail Care
Action: supportive care MAXO:0000950
Regular trimming, filing, and protective measures for dystrophic nails. No disease-modifying treatment is currently available for HED.
Show evidence (1 reference)
PMID:32843087 SUPPORT Human Clinical
"Currently, there are no effective treatments for HED, and gene therapy is just a concept"
Confirms the absence of effective treatments, supporting symptomatic management as the current standard.
Dermatologic Management of Keratoderma
Action: Pharmacotherapy NCIT:C15986
Topical keratolytics (urea, salicylic acid) and emollients for palmoplantar hyperkeratosis.
Hemichannel-Blocking Antibody Therapy (Preclinical)
The monoclonal antibody abEC1.1, which blocks connexin hemichannels, has shown preclinical promise in a Cx30-A88V mouse model of Clouston syndrome. Topical and systemic administration reduced skin cell proliferation and sebaceous gland size, supporting hemichannel blockade as a candidate therapeutic strategy.
Show evidence (1 reference)
PMID:38827992 SUPPORT Other
"Several therapeutics, including non-peptide chemicals, antibodies, mimetic peptides and allele-specific small interfering RNAs are promising in treating connexin-related skin disorders"
Reviews preclinical therapeutic approaches including hemichannel-blocking antibodies for connexin-related skin disorders including Clouston syndrome.
Wig Use for Alopecia
Wigs or hairpieces for cosmetic management of alopecia.
Genetic Counseling
Action: genetic counseling MAXO:0000079
Counseling regarding autosomal dominant inheritance pattern and recurrence risk. Prenatal diagnosis is possible through identification of known family mutations in GJB6.
Show evidence (1 reference)
PMID:32843087 SUPPORT Human Clinical
"fetus carrying the mutation can be identified by prenatal diagnosis, which showed prenatal diagnosis supplies a method to prevent the mutated genes from transmitting to next generation"
Supports the role of genetic counseling and prenatal diagnosis for families with known GJB6 mutations.
{ }

Source YAML

click to show 
name: Clouston Syndrome
creation_date: "2026-04-24T00:00:00Z"
updated_date: "2026-04-24T00:00:00Z"
category: Mendelian
description: >
  Clouston syndrome (hidrotic ectodermal dysplasia, HED; OMIM 129500) is a rare autosomal
  dominant disorder caused by missense mutations in GJB6, encoding the gap junction protein
  connexin 30 (Cx30). It is characterized by the classic triad of nail dystrophy, alopecia,
  and palmoplantar keratoderma, with normal sweat gland function and dentition distinguishing
  it from anhidrotic/hypohidrotic ectodermal dysplasias. The disorder occurs worldwide at
  very low frequency (~1:100,000) but is enriched in French-Canadian populations due to a
  founder effect. Mutant Cx30 causes aberrant hemichannel activity and impaired gap junction
  communication in keratinocytes, hair follicles, and nail matrix.
disease_term:
  preferred_term: Clouston syndrome
  term:
    id: MONDO:0007510
    label: Clouston syndrome
parents:
- Ectodermal Dysplasia
- Palmoplantar Keratoderma
genetic:
- name: GJB6 pathogenic variants
  gene_term:
    preferred_term: GJB6
    term:
      id: hgnc:4288
      label: GJB6
  inheritance:
  - name: Autosomal dominant
    evidence:
    - reference: PMID:32843087
      reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Hidrotic ectodermal dysplasia (HED) (OMIM: 129500), also called Clouston
        syndrome, is a rare autosomal dominant inherited syndrome
      explanation: Directly states autosomal dominant inheritance pattern.
  variants:
  - name: p.Gly11Arg (G11R)
    description: >
      Most common mutation worldwide. Results from c.31G>C substitution in the
      N-terminus of Cx30. Found in French-Canadian, Polish, Lebanese-German,
      and other populations.
    evidence:
    - reference: PMID:25575739
      reference_title: "Phenotypic variability in gap junction syndromic skin disorders: experience from KID and Clouston syndromes' clinical diagnostics."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        a family with Clouston syndrome (caused by p.Gly11Arg mutation in GJB6),
        who are the first reported patients of Polish origin suffering from this
        disorder
      explanation: Reports G11R mutation in a Polish Clouston syndrome family.
    - reference: PMID:23219093
      reference_title: "GJB6, of which mutations underlie Clouston syndrome, is a potential direct target gene of p63."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified a recurrent heterozygous mutation c.31G>C (p.Gly11Arg) in the
        GJB6 gene in the Lebanese-German family with Clouston syndrome
      explanation: Identifies the G11R mutation in a Lebanese-German family.
  - name: p.Ala88Val (A88V)
    description: >
      Second most common mutation, c.263C>T. Introduces a hydrophobic residue
      in the transmembrane M2 domain. Recurrently reported in Chinese Han
      families.
    evidence:
    - reference: PMID:32843087
      reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Sequence analysis revealed she and other 23 family members all carry a
        recurrent missense mutation p.A88V (c.263C > T) in GJB6
      explanation: >-
        Reports the A88V mutation in a large Chinese family with 24 affected
        members across five generations.
  - name: p.Val37Glu (V37E)
    description: Less common mutation identified in HED families.
  - name: p.Asp50Asn (D50N)
    description: Fourth known pathogenic mutation in GJB6 causing HED.
  - name: p.Asn14Ser (N14S)
    description: Novel mutation identified in a Han Chinese pedigree.
    evidence:
    - reference: PMID:25808784
      reference_title: "Novel mutations in GJB6 and GJB2 in Clouston syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We found a novel missense mutation, N14S, in GJB6 and the previously
        identified F191L mutation in GJB2 (Cx26) in a proband with CS in a Han
        Chinese pedigree
      explanation: Reports discovery of the novel N14S mutation in GJB6.
  - name: p.Gly45Ala (G45A)
    description: >
      Novel heterozygous missense variant (c.134G>C) identified in a large Chinese
      pedigree with a unique phenotype including cold-triggered nail pain. Classified
      as likely pathogenic by ACMG criteria.
    evidence:
    - reference: PMID:36645631
      reference_title: "A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We found a novel heterozygous missense variant (c.134G>C:p.G45A) for
        Clouston syndrome
      explanation: Reports a novel pathogenic GJB6 variant in a large Chinese pedigree.
  features: >
    Missense mutations in GJB6, encoding connexin 30 (Cx30), a gap junction protein
    expressed in skin, hair follicles, and nail matrix. At least four recurrent mutations
    (G11R, A88V, V37E, D50N) cause HED. Mutant Cx30 forms dysfunctional gap junctions
    with gain-of-function hemichannel activity, leading to aberrant ATP release that may
    alter paracrine signaling in the epidermis.
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Four mutations (p.G11R, p.A88V, p.V37E and p.D50N) in gap junction beta 6
      (GJB6) gene, which codes connexin30 protein, have been found to cause HED
      in different populations
    explanation: >-
      Establishes the four known pathogenic GJB6 mutations causing hidrotic
      ectodermal dysplasia across different populations.
  - reference: PMID:25808784
    reference_title: "Novel mutations in GJB6 and GJB2 in Clouston syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutations in the GJB6 gene, which encodes the gap junction protein connexin 30,
      have been shown to cause this disorder. To date, four mutations of GJB6 have
      been found in patients with CS: G11R, V37E, D50N and A88V
    explanation: >-
      Confirms the four known GJB6 mutations and reports a novel fifth mutation
      (N14S) in a Chinese pedigree.
  - reference: PMID:23219093
    reference_title: "GJB6, of which mutations underlie Clouston syndrome, is a potential direct target gene of p63."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a recurrent heterozygous mutation c.31G>C (p.Gly11Arg) in the
      GJB6 gene in the Lebanese-German family with Clouston syndrome
    explanation: >-
      Confirms G11R as a recurrent pathogenic mutation and demonstrates Cx30
      expression in hair follicles, nails, and palmoplantar epidermis.
  - reference: CGGV:assertion_ff18d307-80a8-44b8-8b1a-e26e8a7d912a-2018-04-17T160000.000Z
    reference_title: "GJB6 / Clouston syndrome (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "GJB6 | HGNC:4288 | Clouston syndrome | MONDO:0007510 | AD | Definitive"
    explanation: ClinGen classifies the GJB6-Clouston syndrome gene-disease relationship as definitive with autosomal dominant inheritance.
pathophysiology:
- name: Aberrant Hemichannel Activity and ATP Release
  description: >
    The G11R and A88V mutations in Cx30 confer a gain of function, forming
    functional hemichannels at the cell surface that leak ATP into the
    extracellular medium. This aberrant paracrine signaling may alter the
    epidermal factors controlling keratinocyte proliferation and
    differentiation, contributing to the HED phenotype.
  cell_types:
  - preferred_term: Keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: Gap Junction Assembly
    term:
      id: GO:0016264
      label: gap junction assembly
  - preferred_term: Epidermis Development
    term:
      id: GO:0008544
      label: epidermis development
  downstream:
  - target: Impaired Epidermal Differentiation
    description: >-
      Aberrant ATP release from mutant hemichannels disrupts normal keratinocyte
      differentiation and desquamation.
  evidence:
  - reference: PMID:15213106
    reference_title: "Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we document a gain of function of G11R and A88V Cx30, which form functional
      hemichannels at the cell surface and, when expressed in HeLa cells, generate
      a leakage of ATP into the extracellular medium
    explanation: >-
      Demonstrates that HED-causing Cx30 mutations gain hemichannel function,
      releasing ATP that may alter epidermal homeostasis.
- name: Impaired Connexin 30 Trafficking
  description: >
    In the absence of wild-type Cx30, skin disease-associated Cx30 mutations
    show impaired trafficking to the plasma membrane, preventing formation of
    functional gap junctions. This loss-of-function mechanism reduces
    intercellular communication in keratinocytes, complementing the
    hemichannel gain-of-function mechanism.
  cell_types:
  - preferred_term: Keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: Gap Junction Assembly
    term:
      id: GO:0016264
      label: gap junction assembly
  downstream:
  - target: Impaired Epidermal Differentiation
    description: >-
      Reduced gap junction-mediated intercellular communication contributes to
      impaired keratinocyte differentiation and hyperkeratosis.
  evidence:
  - reference: PMID:12419304
    reference_title: "Functional studies of human skin disease- and deafness-associated connexin 30 mutations."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      For all three of the skin disease-associated Cx30 mutations investigated,
      impaired trafficking of the protein to the plasma membrane was observed thus
      preventing the formation of functional Cx30 gap junctions
    explanation: >-
      Shows that skin disease-associated Cx30 mutations impair protein trafficking,
      preventing normal gap junction formation in keratinocytes.
- name: Impaired Epidermal Differentiation
  description: >
    Dysfunctional gap junction communication in keratinocytes disrupts normal
    epidermal differentiation and desquamation. Reduced intercellular coupling
    combined with aberrant hemichannel-mediated ATP signaling leads to
    hyperkeratosis, particularly in the palmoplantar epidermis where Cx30
    is normally highly expressed.
  cell_types:
  - preferred_term: Keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: Keratinocyte Differentiation
    term:
      id: GO:0030216
      label: keratinocyte differentiation
  evidence:
  - reference: PMID:15213106
    reference_title: "Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Such increased ATP levels might act as a paracrine messenger that, by altering
      the epidermal factors which control the proliferation and differentiation of
      keratinocytes, may play an important role in the pathophysiological processes
      leading to the HED phenotype
    explanation: >-
      Proposes mechanism by which aberrant ATP release from mutant hemichannels
      disrupts keratinocyte differentiation.
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moderate to severe hyperkeratosis is often present, with reduced keratinocytes
      desquamation
    explanation: >-
      Clinical observation confirming impaired keratinocyte desquamation as part
      of the Clouston syndrome epidermal phenotype.
- name: Hair Follicle Dysfunction
  description: >
    Connexin 30 is normally expressed in the inner root sheath and cortex of
    hair follicles. Mutations disrupt intercellular gap junction signaling in
    the hair follicle, leading to progressive alopecia. Hair is characteristically
    dry, fine, and brittle, and may be completely absent from the scalp, axillary,
    and pubic regions.
  cell_types:
  - preferred_term: Hair Follicle Cell
    term:
      id: CL:0002559
      label: hair follicle cell
  biological_processes:
  - preferred_term: Hair Cycle
    term:
      id: GO:0042633
      label: hair cycle
  evidence:
  - reference: PMID:23219093
    reference_title: "GJB6, of which mutations underlie Clouston syndrome, is a potential direct target gene of p63."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Immunostaining in normal human skin sections demonstrated predominant
      expression of Cx30 in hair follicles, nails, and palmoplantar epidermis
    explanation: >-
      Establishes that Cx30 is predominantly expressed in hair follicles,
      explaining why GJB6 mutations cause alopecia.
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Skin biopsy of trunk showed hyperkeratosis with normal distribution of
      eccrine and sebaceous gland, but absence of hair follicles
    explanation: >-
      Histological finding showing complete absence of hair follicles in
      affected skin of a patient with the A88V mutation.
- name: Nail Matrix Disruption
  description: >
    Dysfunctional gap junctions in the nail matrix impair normal nail plate
    formation. Nail dystrophy is often the earliest and most consistent feature,
    with nails becoming thick, hyperplastic, deformed, and showing onycholysis.
    Some patients show unusual pterygium formation and nail thinning.
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      nails are predominantly affected. They are thick, hyperplastic, and
      deformed with onycholysis
    explanation: >-
      Describes the characteristic nail pathology in Clouston syndrome as the
      predominant clinical feature.
phenotypes:
- category: Dermatologic
  name: Nail Dystrophy
  description: >
    Severe nail changes are the most consistent feature, present from birth or
    early childhood. Nails are thickened, hyperplastic, deformed with
    onycholysis, subungual hyperkeratosis, and yellow discoloration. Some
    patients show unusual pterygium formation and nail thinning. Cold-triggered
    nail pain has been reported in a pedigree with the G45A variant.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Nail dystrophy
    term:
      id: HP:0008404
      label: Nail dystrophy
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      nails are predominantly affected. They are thick, hyperplastic, and
      deformed with onycholysis
    explanation: >-
      Describes nail dystrophy as the predominant clinical feature in Clouston
      syndrome.
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Physical examination revealed that her fingernails and toenails are atrophic,
      short, thickened and brittle with pterygium formation
    explanation: >-
      Clinical description of nail changes in a Chinese patient with A88V mutation.
  - reference: PMID:36645631
    reference_title: "A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a new clinical phenotype involving all nail needling pain
      in all patients
    explanation: >-
      Reports cold-triggered nail pain as a novel clinical feature in a G45A
      pedigree.
- category: Dermatologic
  name: Alopecia
  description: >
    Progressive hair loss beginning in childhood, ranging from sparse, fine,
    brittle hair to total alopecia. Eyebrows, eyelashes, and body hair may
    also be affected. Hair loss may be progressive, with some patients losing
    hair after puberty.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Alopecia
    term:
      id: HP:0001596
      label: Alopecia
  evidence:
  - reference: PMID:15213106
    reference_title: "Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Clouston syndrome or hidrotic ectodermal dysplasia (HED) is a rare dominant
      genodermatosis characterized by palmoplantar hyperkeratosis, generalized
      alopecia and nail defects
    explanation: >-
      Confirms generalized alopecia as a cardinal feature of Clouston syndrome.
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hair is dry, fine, and brittle, and may be absent from the scalp, axillary,
      and pubic region
    explanation: Clinical description of hair changes in Clouston syndrome.
- category: Dermatologic
  name: Palmoplantar Keratoderma
  description: >
    Diffuse thickening of the skin on palms and soles. A hallmark feature
    of hidrotic ectodermal dysplasia, though variable in severity and
    occasionally absent.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Diffuse palmoplantar hyperkeratosis
    term:
      id: HP:0007447
      label: Diffuse palmoplantar hyperkeratosis
  evidence:
  - reference: PMID:15213106
    reference_title: "Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Clouston syndrome or hidrotic ectodermal dysplasia (HED) is a rare dominant
      genodermatosis characterized by palmoplantar hyperkeratosis, generalized
      alopecia and nail defects
    explanation: >-
      Identifies palmoplantar hyperkeratosis as one of the three cardinal
      features of Clouston syndrome.
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clouston syndrome is characterized by nail dystrophy, hypotrichosis, and
      palmoplantar keratoderma
    explanation: >-
      Confirms palmoplantar keratoderma as a core diagnostic feature of
      Clouston syndrome.
- category: Dermatologic
  name: Follicular Hyperkeratosis
  description: >
    Dense follicular hyperkeratotic papules over the body surface, representing
    thickened skin with hyperkeratosis extending beyond the palms and soles.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Follicular hyperkeratosis
    term:
      id: HP:0007502
      label: Follicular hyperkeratosis
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skin all over her body is thickened and hyperkeratosis with dense
      follicular hyperkeratotic papules
    explanation: >-
      Reports follicular hyperkeratotic papules as a clinical feature in an
      affected Chinese patient.
- category: Dermatologic
  name: Hyperpigmentation
  description: >
    Darkening of skin, particularly over joints such as knuckles, elbows,
    and knees.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hyperpigmentation of the skin
    term:
      id: HP:0000953
      label: Hyperpigmentation of the skin
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skin of his palms and soles was hyperkeratotic and mildly
      hyperpigmented on the joints
    explanation: >-
      Clinical observation of hyperpigmentation over joints in an affected
      father with Clouston syndrome.
- category: Dermatologic
  name: Sparse Eyebrows
  description: >
    Eyebrows may be sparse or absent in affected individuals, as part
    of the broader hypotrichosis phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sparse eyebrow
    term:
      id: HP:0045075
      label: Sparse eyebrow
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      sparse eyebrows and eyelashes
    explanation: >-
      Describes sparse eyebrows in a Clouston syndrome patient.
- category: Dermatologic
  name: Sparse Eyelashes
  description: >
    Eyelashes may be sparse or absent in affected individuals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sparse eyelashes
    term:
      id: HP:0000653
      label: Sparse eyelashes
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      sparse eyebrows and eyelashes
    explanation: >-
      Describes sparse eyelashes in a Clouston syndrome patient.
- category: Neurological
  name: Sensorineural Hearing Loss
  description: >
    Hearing impairment has been reported in some patients with GJB6
    mutations. While Cx30 is expressed in the inner ear, hearing loss is
    not a consistent feature of Clouston syndrome and may relate to
    specific mutations or additional genetic modifiers.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Only two patients have hearing disorders (the proband and her father)
    explanation: >-
      Reports sensorineural hearing loss in 2 of 24 affected family members
      with the A88V mutation, indicating low frequency.
diagnosis:
- name: Clinical Diagnosis
  description: >
    Clinical recognition is based on the classic triad of nail dystrophy,
    hypotrichosis/alopecia, and palmoplantar keratoderma with preserved
    sweating and normal dentition. Phenotypic overlap with other
    genodermatoses and intrafamilial variability can confound diagnosis.
  evidence:
  - reference: PMID:25575739
    reference_title: "Phenotypic variability in gap junction syndromic skin disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      proper diagnosis of these syndromes is still challenging and should
      always be followed by molecular verification
    explanation: >-
      Emphasizes diagnostic difficulty due to phenotypic variability and
      the necessity of molecular confirmation.
- name: Molecular Genetic Testing
  description: >
    Sanger sequencing or whole-exome sequencing of GJB6 to identify
    pathogenic missense variants. Molecular confirmation is strongly
    recommended due to phenotypic overlap with other ectodermal
    dysplasias and connexin disorders.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: MAXO:0000533
      label: molecular genetic testing
  evidence:
  - reference: PMID:36645631
    reference_title: "A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      genetic testing is necessary for the diagnosis of Clouston syndrome
    explanation: >-
      Concludes that molecular genetic testing is essential for definitive
      diagnosis.
histopathology:
- name: Absence of Hair Follicles with Preserved Eccrine Glands
  description: >
    Skin biopsy shows hyperkeratosis with absence of hair follicles but
    normal distribution of eccrine and sebaceous glands. This pattern
    distinguishes Clouston syndrome from anhidrotic ectodermal dysplasias.
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Skin biopsy of trunk showed hyperkeratosis with normal distribution
      of eccrine and sebaceous gland, but absence of hair follicles
    explanation: >-
      Histopathological finding in an affected patient confirming the
      characteristic pattern of absent hair follicles with preserved glands.
treatments:
- name: Symptomatic Nail Care
  description: >
    Regular trimming, filing, and protective measures for dystrophic nails.
    No disease-modifying treatment is currently available for HED.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Currently, there are no effective treatments for HED, and gene therapy
      is just a concept
    explanation: >-
      Confirms the absence of effective treatments, supporting symptomatic
      management as the current standard.
- name: Dermatologic Management of Keratoderma
  description: >
    Topical keratolytics (urea, salicylic acid) and emollients for
    palmoplantar hyperkeratosis.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
- name: Hemichannel-Blocking Antibody Therapy (Preclinical)
  description: >
    The monoclonal antibody abEC1.1, which blocks connexin hemichannels, has shown
    preclinical promise in a Cx30-A88V mouse model of Clouston syndrome. Topical
    and systemic administration reduced skin cell proliferation and sebaceous gland
    size, supporting hemichannel blockade as a candidate therapeutic strategy.
  evidence:
  - reference: PMID:38827992
    reference_title: "Connexins in epidermal health and diseases: insights into their mutations, implications, and therapeutic solutions."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Several therapeutics, including non-peptide chemicals, antibodies, mimetic
      peptides and allele-specific small interfering RNAs are promising in treating
      connexin-related skin disorders
    explanation: >-
      Reviews preclinical therapeutic approaches including hemichannel-blocking
      antibodies for connexin-related skin disorders including Clouston syndrome.
- name: Wig Use for Alopecia
  description: >
    Wigs or hairpieces for cosmetic management of alopecia.
- name: Genetic Counseling
  description: >
    Counseling regarding autosomal dominant inheritance pattern and recurrence
    risk. Prenatal diagnosis is possible through identification of known
    family mutations in GJB6.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
  evidence:
  - reference: PMID:32843087
    reference_title: "A recurrent mutation of GJB6 in a big Chinese family with Hidrotic ectodermal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      fetus carrying the mutation can be identified by prenatal diagnosis,
      which showed prenatal diagnosis supplies a method to prevent the mutated
      genes from transmitting to next generation
    explanation: >-
      Supports the role of genetic counseling and prenatal diagnosis for
      families with known GJB6 mutations.
datasets:
📚

References & Deep Research

Deep Research

1
Falcon ▸
Clouston Syndrome (Hidrotic Ectodermal Dysplasia 2; HED2): Comprehensive Disease Characteristics Report
Edison Scientific Literature 23 citations 2026-04-24T18:21:18.540709

Clouston Syndrome (Hidrotic Ectodermal Dysplasia 2; HED2): Comprehensive Disease Characteristics Report

Executive summary (current understanding)

Clouston syndrome is a rare autosomal dominant ectodermal dysplasia primarily affecting hair, nails, and palmoplantar skin, classically presenting with the triad of nail dystrophy, hypotrichosis/alopecia, and palmoplantar hyperkeratosis, typically with normal sweating and normal dentition (OMIM #129500). Core evidence includes a large 2023 multi-generation Chinese pedigree study identifying a novel GJB6 variant and detailing age-related clinical evolution, and mechanistic 2024 synthesis highlighting connexin hemichannel gain-of-function as a therapeutic target. (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3, yasarbas2024connexinsinepidermal pages 15-17)

1. Disease information

1.1 Disease overview

Clouston syndrome (hidrotic ectodermal dysplasia type 2) is an ectodermal dysplasia characterized by the triad of nail dystrophy, partial-to-complete alopecia/hypotrichosis, and palmoplantar hyperkeratosis, with no sweat gland or tooth abnormalities in typical cases. (huang2023anovelvariant pages 1-2)

Direct abstract quote (2023, Frontiers of Medicine): “Clouston syndrome (OMIM #129500), also known as hidrotic ectodermal dysplasia type 2, is a rare autosomal dominant skin disorder.” (huang2023anovelvariant pages 1-2)

1.2 Key identifiers (available from retrieved full text)

  • OMIM: 129500 (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • ICD-10 (used in a Danish ectodermal dysplasia cohort): Q82.4B “dysplasia ectodermalis hidrotica” (used for case ascertainment; Clouston syndrome was the second most common condition in that cohort). (svendsen2014aretrospectivestudy pages 1-2)
  • MONDO / Orphanet / MeSH: Not directly retrievable from the full-text sources obtained in this run; therefore not asserted here.

1.3 Synonyms / alternative names

  • Hidrotic ectodermal dysplasia type 2; hidrotic ectodermal dysplasia 2 (HED2) (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • “Ectodermal dysplasia 2, Clouston type (ECTD2)” (as listed in a 2024 classification-oriented text) (peschel2024differentialdiagnostischeeinordnungektodermaler pages 22-23)

1.4 Evidence source type

Most disease information here is derived from aggregated disease-level resources embedded in primary/review literature (OMIM-linked descriptions) and from individual/family-based studies (case/family cohorts with molecular confirmation). (huang2023anovelvariant pages 1-2, kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3, baris2008anovelgjb6 pages 1-3)

2. Etiology

2.1 Primary causal factors

Genetic etiology: Pathogenic variants in GJB6 (encoding connexin 30, Cx30) cause Clouston syndrome. (baris2008anovelgjb6 pages 1-3, huang2023anovelvariant pages 1-2)

  • Baris et al. (2008) states positional cloning identified GJB6 on chromosome 13q12 as the causative gene; the disorder is autosomal dominant with hair, nail, and palmoplantar findings and normal sweating/dentition. (baris2008anovelgjb6 pages 1-3)

2.2 Risk factors

  • Genetic risk factor: having a heterozygous pathogenic variant in GJB6 (autosomal dominant). (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • Family history: consistent with autosomal dominant segregation in large pedigrees. (huang2023anovelvariant pages 2-4)

No credible environmental/toxic/infectious risk factors were identified in the retrieved corpus.

2.3 Protective factors

No protective genetic or environmental factors were identified in the retrieved corpus.

2.4 Gene–environment interactions

No gene–environment interaction evidence was identified in the retrieved corpus.

3. Phenotypes

3.1 Core phenotype spectrum

Canonical triad and typical sparing of sweat glands/teeth - Nail dystrophy, hypotrichosis/alopecia, palmoplantar hyperkeratosis; sweating and dentition typically normal. (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)

Detailed phenotypes from a large 2023 pedigree (China; 60 individuals, 22 affected): - Hair: absent/sparse scalp hair, eyebrows, eyelashes from birth in the proband; severity may intensify with age. (huang2023anovelvariant pages 1-2) - Nails: curvature increase by ~5–6 months; thickened/shortened/slow-growing by ~1 year in the proband. (huang2023anovelvariant pages 1-2) - Palmoplantar keratoderma/hyperkeratosis: developed gradually after puberty in the proband; palms mild, soles more obvious. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 2-4) - Sweat glands/teeth/hearing/cognition: reported as normal in that pedigree. (huang2023anovelvariant pages 1-2)

Novel/expanded phenotype (2023 pedigree): “all nail needling pain” (cold-triggered nail pain is described in the study body) (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 4-7)

3.2 Onset, severity, progression

  • Onset: can be congenital/early-life for hair and nail changes (birth to infancy). (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • Progression: variable expressivity; in the 2023 pedigree, palmoplantar hyperkeratosis emerged after puberty and some individuals worsened with age while others improved. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 2-4)
  • Variable expressivity: documented within families; mild forms can complicate diagnosis. (kutkowskakazmierczak2015phenotypicvariabilityin pages 3-5)

3.3 Suggested HPO terms (non-exhaustive; for knowledge base population)

(ontology suggestions; not claims of frequency unless noted above) - Nail dystrophy: HP:0002164 - Onycholysis: HP:0001806 - Palmoplantar keratoderma: HP:0000972 - Alopecia: HP:0001596 - Hypotrichosis: HP:0001006 - Sparse eyebrows: HP:0000535 - Sparse eyelashes: HP:0000653 - Normal sweating (as absence of hypohidrosis): HP:0000970 is hypohidrosis (use negation/absence where supported) (baris2008anovelgjb6 pages 1-3)

3.4 Quality of life impact

The retrieved sources did not include standardized quality-of-life instruments. However, clinically, nail dystrophy and palmoplantar hyperkeratosis can plausibly impair function and cause pain; in the 2023 pedigree, cold-triggered nail pain was severe (NRS values described in the paper body). (huang2023anovelvariant pages 4-7)

4. Genetic / molecular information

4.1 Causal gene

  • GJB6 (connexin 30, Cx30) (baris2008anovelgjb6 pages 1-3, huang2023anovelvariant pages 1-2)

4.2 Pathogenic variants (reported in retrieved primary literature)

Variants repeatedly referenced as confirmed disease-causing in Clouston syndrome: - G11R, V37E, A88V, D50N (huang2023anovelvariant pages 1-2)

Examples with specific evidence and mapping - D50N: Baris et al. (2008) reports heterozygous nucleotide 148 G>A leading to D50N in the first extracellular loop (E1) in a mother and son with HED2. (baris2008anovelgjb6 pages 1-3) - p.Gly11Arg (c.31G>C): reported in a Polish family with Clouston syndrome; authors emphasize diagnostic difficulty due to variability. (kutkowskakazmierczak2015phenotypicvariabilityin pages 3-5) - c.134G>C (p.G45A): novel heterozygous missense variant reported in a large Chinese pedigree; absent from gnomAD in the study’s report and classified as likely pathogenic by ACMG criteria. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 2-4)

Domain localization (from 2023 synthesis within the pedigree paper): - G11R in cytoplasmic N-terminus; V37E in M1; A88V in M2; D50N in E1; and the newly reported G45A in an adjacent membrane region. (huang2023anovelvariant pages 7-8)

4.3 Variant consequences (functional class)

A current mechanistic theme is hemichannel gain-of-function (“hyperactive hemichannels”) for at least some Cx30 mutants (e.g., A88V, G11R) with downstream ATP/Ca2+ signaling effects in keratinocytes, alongside trafficking/gap-junction effects that may be context dependent. (yasarbas2024connexinsinepidermal pages 11-12, yasarbas2024connexinsinepidermal pages 15-17)

4.4 Modifier genes / epigenetics

The 2023 pedigree study discusses potential reasons for intrafamilial variability (e.g., polymorphisms in keratins/connexins and regulatory-region variants) and suggests sequencing regulatory regions, but specific validated modifier genes were not established in the retrieved text. (huang2023anovelvariant pages 7-8)

5. Environmental information

No specific environmental, lifestyle, or infectious contributors were identified in the retrieved corpus. Clouston syndrome is primarily a monogenic disorder (GJB6). (baris2008anovelgjb6 pages 1-3, huang2023anovelvariant pages 1-2)

6. Mechanism / pathophysiology (prioritizing 2024–2023)

6.1 Connexin biology and pathogenic mechanism

Connexins form gap junction channels (cell-to-cell) and can also form hemichannels (cell-to-extracellular). A key disease mechanism highlighted in recent work is hyperactive (“leaky”) hemichannel activity, enabling abnormal flux of signaling molecules such as ATP and Ca2+, which can disrupt keratinocyte proliferation/differentiation programs. (yasarbas2024connexinsinepidermal pages 15-17, yasarbas2024connexinsinepidermal pages 11-12)

6.2 Causal chain (example: Cx30-A88V)

  1. GJB6 missense variant → mutant Cx30 with altered trafficking/function (some context-dependent rescue by WT co-expression). (yasarbas2024connexinsinepidermal pages 11-12)
  2. Hyperactive hemichannels → increased ATP release and Ca2+ influx signaling. (yasarbas2024connexinsinepidermal pages 11-12, yasarbas2024connexinsinepidermal pages 15-17)
  3. Altered keratinocyte behavior (proliferation/differentiation) and adnexal effects (e.g., sebaceous gland enlargement in models) → clinical hyperkeratosis and appendage phenotypes. (yasarbas2024connexinsinepidermal pages 11-12)

6.3 Pathways / GO / cell types (suggestions)

  • Suggested GO Biological Process terms:
  • Gap junction assembly (GO:1904322)
  • Cell–cell junction organization (GO:0045216)
  • Epidermis development (GO:0008544)
  • Keratinocyte differentiation (GO:0030216)
  • ATP metabolic/signaling processes (context-dependent)
  • Suggested Cell Ontology (CL) terms:
  • Keratinocyte (CL:0000312)
  • Sebocyte (CL:0000638)

6.4 Model systems / molecular profiling

  • A Cx30-A88V mouse model recapitulated key features including “mild palmoplantar hyperkeratosis, enlarged sebaceous glands, and deafness,” and was used to validate hemichannel blockade strategies. (yasarbas2024connexinsinepidermal pages 11-12)
  • The 2023 family study used histopathology and hair microscopy/SEM to characterize hair follicle scarcity and distinctive hair ultrastructure. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 2-4)

7. Anatomical structures affected

7.1 Organ/system level (primary)

  • Skin and appendages: hair follicles, nails, palmoplantar epidermis. (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)

7.2 Tissue/cell level (suggestions)

  • Epidermis (keratinocytes), hair follicle outer root sheath (Cx30 expression referenced in discussion), nail bed dermis with superficial vessels (reported histology in the 2023 pedigree). (huang2023anovelvariant pages 2-4)

7.3 UBERON suggestions

  • Skin of body (UBERON:0002097)
  • Hair follicle (UBERON:0002199)
  • Nail (UBERON:0001708)
  • Palm skin (UBERON:0001456) / sole of foot skin (use relevant UBERON terms)

8. Temporal development

  • Congenital/early childhood onset is common for hair and nail findings in reported cases. (baris2008anovelgjb6 pages 1-3, huang2023anovelvariant pages 1-2)
  • Adolescent/post-pubertal development of palmoplantar hyperkeratosis was documented in the 2023 pedigree’s proband. (huang2023anovelvariant pages 1-2)
  • Course is variable, including worsening with age in some and partial self-improvement in others (intrafamilial variability). (huang2023anovelvariant pages 2-4)

9. Inheritance and population

9.1 Inheritance, penetrance, expressivity

  • Autosomal dominant inheritance is repeatedly stated. (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • Variable expressivity is well documented, including mild presentations that could be misclassified without molecular testing. (kutkowskakazmierczak2015phenotypicvariabilityin pages 3-5, kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)

9.2 Epidemiology (available statistics)

  • Prevalence estimate (global): “affecting 1 out of 100 000 individuals” (from the 2023 paper’s introduction). (huang2023anovelvariant pages 1-2)
  • Danish clinical cohort context (1994–2013): In a retrospective study of 45 Danish ED families, Clouston syndrome was the second most common condition (n=10 patients, 4 families) among ED diagnoses captured via ICD-10 codes including Q82.4B. This is not a prevalence estimate, but provides real-world ascertainment frequency in a tertiary center cohort. (svendsen2014aretrospectivestudy pages 1-2)

9.3 Population/variant notes

  • The 2023 pedigree paper summarizes that G11R and A88V are common in Chinese pedigree reports, and catalogs multiple variants across diverse reported ancestries. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 7-8)

10. Diagnostics

10.1 Clinical diagnosis

Clinical recognition is based on the triad (nail, hair, palmoplantar keratoderma) with preserved sweating and teeth; however, phenotypic overlap with other genodermatoses and intrafamilial variability can confound diagnosis. (kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)

10.2 Genetic testing (recommended approach based on evidence)

  • Molecular confirmation is strongly recommended.
  • Kutkowska-Kaźmierczak et al. (2015) abstract conclusion: “proper diagnosis of these syndromes is still challenging and should always be followed by molecular verification.” (kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)
  • The 2023 pedigree paper concludes that “genetic testing is necessary for the diagnosis of Clouston syndrome.” (huang2023anovelvariant pages 1-2)
  • Testing modalities used in key reports include whole-exome sequencing (WES) followed by Sanger sequencing for segregation/confirmation. (huang2023anovelvariant pages 1-2, huang2023anovelvariant pages 2-4)

10.3 Histology / ancillary studies

  • Scalp biopsy in Clouston may show absent hair follicles with preserved eccrine/sebaceous gland distribution (documented both in 2008 and 2023 reports). (baris2008anovelgjb6 pages 1-3, huang2023anovelvariant pages 2-4)

10.4 Differential diagnosis (examples from retrieved sources)

Connexin-related and ectodermal dysplasia differential considerations include other hair–nail disorders and keratodermas; in practice, overlap can necessitate testing of multiple connexin genes. (kutkowskakazmierczak2015phenotypicvariabilityin pages 5-6, kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)

11. Outcome / prognosis

The retrieved sources do not report disease-specific survival statistics for Clouston syndrome. The condition is generally described as affecting ectodermal appendages; major morbidity relates to hair/nail/keratoderma burden and potentially pain.

Mechanistic/model evidence indicates mutant Cx30 can drive proliferative epidermal pathology in vivo, which is relevant to long-term monitoring, but Clouston-specific carcinoma risk statistics were not found in the retrieved corpus. (yasarbas2024connexinsinepidermal pages 11-12)

12. Treatment

12.1 Current standard of care

No disease-modifying therapy for Clouston syndrome was identified in the retrieved sources. Management is therefore inferred to be supportive/symptomatic (e.g., keratoderma care; nail care; pain management), but specific regimens were not detailed in the extracted texts.

12.2 Recent developments / experimental therapeutics (2024–2023 prioritized)

A major 2024 development theme is targeting connexin hemichannels (and related connexin-directed strategies) for connexinopathies.

  • Hemichannel-blocking antibody approach (preclinical, Clouston model):
  • A 2024 review reports that the monoclonal antibody abEC1.1 “also blocked the Cx30-A88V hyperactive hemichannels in Clouston syndrome mouse model,” and that topical/systemic administration reduced skin cell proliferation and sebaceous gland size (supporting hemichannel blockade as a candidate strategy). (yasarbas2024connexinsinepidermal pages 15-17)
  • Allele-specific RNA interference / antisense strategies (platform approaches; not Clouston-specific clinical trials):
  • The same 2024 review summarizes allele-specific RNAi and antisense oligonucleotide approaches used in related dominant skin disorders and highlights their promise for single-nucleotide pathogenic variants. (yasarbas2024connexinsinepidermal pages 15-17)

12.3 MAXO term suggestions (supportive mapping)

  • Symptomatic management of hyperkeratosis: MAXO:0000759 (Skin care) (suggested)
  • Genetic testing: MAXO:0000127 (Genetic testing) (supported by repeated recommendations for molecular verification) (huang2023anovelvariant pages 1-2, kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)
  • Genetic counseling: MAXO:0000079 (Genetic counseling) (implied by autosomal dominant inheritance and family-based testing) (huang2023anovelvariant pages 1-2, baris2008anovelgjb6 pages 1-3)
  • Experimental hemichannel-blocking antibody therapy: map to a therapeutic antibody intervention term (MAXO suggestion; preclinical) (yasarbas2024connexinsinepidermal pages 15-17)

13. Prevention

Primary prevention is not applicable for an autosomal dominant Mendelian disorder except via reproductive options.

Secondary/tertiary prevention: - Cascade testing in families and early diagnosis to guide supportive care and anticipate complications is supported by the emphasis on molecular confirmation and pedigree evaluation. (huang2023anovelvariant pages 2-4, kutkowskakazmierczak2015phenotypicvariabilityin pages 7-8)

14. Other species / natural disease

No naturally occurring non-human Clouston syndrome analog was identified in the retrieved corpus.

15. Model organisms

  • Mouse model (Cx30-A88V): used to study phenotype and test hemichannel-blocking approaches; recapitulated palmoplantar hyperkeratosis and sebaceous gland enlargement (and deafness in mice). (yasarbas2024connexinsinepidermal pages 11-12)

Notes on evidence gaps (important for knowledge base curation)

  • Orphanet ID, MeSH ID, and MONDO ID were not extractable from the retrieved full-text literature in this run; direct database lookups would be required for completeness.
  • Clouston-specific standardized QoL measures, penetrance estimates, and robust population prevalence/incidence are limited in the retrieved corpus; one prevalence estimate (1/100,000) is provided in the 2023 pedigree paper introduction. (huang2023anovelvariant pages 1-2)

Key recent sources (URLs and publication dates)

  • Huang H, et al. Frontiers of Medicine. Jan 2023. “A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome.” https://doi.org/10.1007/s11684-022-0933-2 (huang2023anovelvariant pages 1-2)
  • Yasarbas SS, et al. Frontiers in Physiology. May 2024. “Connexins in epidermal health and diseases: insights into their mutations, implications, and therapeutic solutions.” https://doi.org/10.3389/fphys.2024.1346971 (yasarbas2024connexinsinepidermal pages 15-17)
  • Baris HN, et al. British Journal of Dermatology. Dec 2008. “A novel GJB6 missense mutation in hidrotic ectodermal dysplasia 2 (Clouston syndrome)…” https://doi.org/10.1111/j.1365-2133.2008.08796.x (baris2008anovelgjb6 pages 1-3)
  • Kutkowska-Kaźmierczak A, et al. Journal of Applied Genetics. Published online 10 Jan 2015 (issue year 2015). https://doi.org/10.1007/s13353-014-0266-1 (kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3)
  • Svendsen MT, et al. Acta Dermato-Venereologica. Epub ahead of print Feb 4, 2014. https://doi.org/10.2340/00015555-1799 (svendsen2014aretrospectivestudy pages 1-2)

References

  1. (huang2023anovelvariant pages 1-2): Hequn Huang, Mengyun Chen, Xia Liu, Xixi Xiong, Lanbo Zhou, Zhonglan Su, Yan Lu, and Bo Liang. A novel variant in the gjb6 gene in a large chinese family with a unique phenotype of clouston syndrome. Frontiers of Medicine, 17:330-338, Jan 2023. URL: https://doi.org/10.1007/s11684-022-0933-2, doi:10.1007/s11684-022-0933-2. This article has 1 citations.

  2. (baris2008anovelgjb6 pages 1-3): Hagit N. Baris, Abraham Zlotogorski, G. Peretz-Amit, V. Doviner, Mordechai Shohat, H. Reznik‐Wolf, and E. Pras. A novel gjb6 missense mutation in hidrotic ectodermal dysplasia 2 (clouston syndrome) broadens its genotypic basis. British Journal of Dermatology, 159:1373-1376, Dec 2008. URL: https://doi.org/10.1111/j.1365-2133.2008.08796.x, doi:10.1111/j.1365-2133.2008.08796.x. This article has 47 citations and is from a highest quality peer-reviewed journal.

  3. (yasarbas2024connexinsinepidermal pages 15-17): S. Suheda Yasarbas, Ece Inal, M. Azra Yildirim, Sandrine Dubrac, Jérôme Lamartine, and Gulistan Mese. Connexins in epidermal health and diseases: insights into their mutations, implications, and therapeutic solutions. Frontiers in Physiology, May 2024. URL: https://doi.org/10.3389/fphys.2024.1346971, doi:10.3389/fphys.2024.1346971. This article has 20 citations.

  4. (svendsen2014aretrospectivestudy pages 1-2): M. Svendsen, E. Henningsen, J. Hertz, Dorthe Vestergaard Grejsen, and A. Bygum. A retrospective study of clinical and mutational findings in 45 danish families with ectodermal dysplasia. Acta dermato-venereologica, 94 5:531-3, Feb 2014. URL: https://doi.org/10.2340/00015555-1799, doi:10.2340/00015555-1799. This article has 19 citations and is from a domain leading peer-reviewed journal.

  5. (peschel2024differentialdiagnostischeeinordnungektodermaler pages 22-23): Nicolai Peschel. Differentialdiagnostische einordnung ektodermaler dysplasien auf der basis molekularer signalwege. Text, Jan 2024. URL: https://doi.org/10.25593/open-fau-805, doi:10.25593/open-fau-805. This article has 0 citations and is from a peer-reviewed journal.

  6. (kutkowskakazmierczak2015phenotypicvariabilityin pages 1-3): Anna Kutkowska-Kaźmierczak, Katarzyna Niepokój, Katarzyna Wertheim-Tysarowska, Aleksandra Giza, Maria Mordasewicz-Goliszewska, Jerzy Bal, and Ewa Obersztyn. Phenotypic variability in gap junction syndromic skin disorders: experience from kid and clouston syndromes’ clinical diagnostics. Journal of Applied Genetics, 56:329-337, Jan 2015. URL: https://doi.org/10.1007/s13353-014-0266-1, doi:10.1007/s13353-014-0266-1. This article has 18 citations and is from a peer-reviewed journal.

  7. (huang2023anovelvariant pages 2-4): Hequn Huang, Mengyun Chen, Xia Liu, Xixi Xiong, Lanbo Zhou, Zhonglan Su, Yan Lu, and Bo Liang. A novel variant in the gjb6 gene in a large chinese family with a unique phenotype of clouston syndrome. Frontiers of Medicine, 17:330-338, Jan 2023. URL: https://doi.org/10.1007/s11684-022-0933-2, doi:10.1007/s11684-022-0933-2. This article has 1 citations.

  8. (huang2023anovelvariant pages 4-7): Hequn Huang, Mengyun Chen, Xia Liu, Xixi Xiong, Lanbo Zhou, Zhonglan Su, Yan Lu, and Bo Liang. A novel variant in the gjb6 gene in a large chinese family with a unique phenotype of clouston syndrome. Frontiers of Medicine, 17:330-338, Jan 2023. URL: https://doi.org/10.1007/s11684-022-0933-2, doi:10.1007/s11684-022-0933-2. This article has 1 citations.

  9. (kutkowskakazmierczak2015phenotypicvariabilityin pages 3-5): Anna Kutkowska-Kaźmierczak, Katarzyna Niepokój, Katarzyna Wertheim-Tysarowska, Aleksandra Giza, Maria Mordasewicz-Goliszewska, Jerzy Bal, and Ewa Obersztyn. Phenotypic variability in gap junction syndromic skin disorders: experience from kid and clouston syndromes’ clinical diagnostics. Journal of Applied Genetics, 56:329-337, Jan 2015. URL: https://doi.org/10.1007/s13353-014-0266-1, doi:10.1007/s13353-014-0266-1. This article has 18 citations and is from a peer-reviewed journal.

  10. (huang2023anovelvariant pages 7-8): Hequn Huang, Mengyun Chen, Xia Liu, Xixi Xiong, Lanbo Zhou, Zhonglan Su, Yan Lu, and Bo Liang. A novel variant in the gjb6 gene in a large chinese family with a unique phenotype of clouston syndrome. Frontiers of Medicine, 17:330-338, Jan 2023. URL: https://doi.org/10.1007/s11684-022-0933-2, doi:10.1007/s11684-022-0933-2. This article has 1 citations.

  11. (yasarbas2024connexinsinepidermal pages 11-12): S. Suheda Yasarbas, Ece Inal, M. Azra Yildirim, Sandrine Dubrac, Jérôme Lamartine, and Gulistan Mese. Connexins in epidermal health and diseases: insights into their mutations, implications, and therapeutic solutions. Frontiers in Physiology, May 2024. URL: https://doi.org/10.3389/fphys.2024.1346971, doi:10.3389/fphys.2024.1346971. This article has 20 citations.

  12. (kutkowskakazmierczak2015phenotypicvariabilityin pages 5-6): Anna Kutkowska-Kaźmierczak, Katarzyna Niepokój, Katarzyna Wertheim-Tysarowska, Aleksandra Giza, Maria Mordasewicz-Goliszewska, Jerzy Bal, and Ewa Obersztyn. Phenotypic variability in gap junction syndromic skin disorders: experience from kid and clouston syndromes’ clinical diagnostics. Journal of Applied Genetics, 56:329-337, Jan 2015. URL: https://doi.org/10.1007/s13353-014-0266-1, doi:10.1007/s13353-014-0266-1. This article has 18 citations and is from a peer-reviewed journal.

  13. (kutkowskakazmierczak2015phenotypicvariabilityin pages 7-8): Anna Kutkowska-Kaźmierczak, Katarzyna Niepokój, Katarzyna Wertheim-Tysarowska, Aleksandra Giza, Maria Mordasewicz-Goliszewska, Jerzy Bal, and Ewa Obersztyn. Phenotypic variability in gap junction syndromic skin disorders: experience from kid and clouston syndromes’ clinical diagnostics. Journal of Applied Genetics, 56:329-337, Jan 2015. URL: https://doi.org/10.1007/s13353-014-0266-1, doi:10.1007/s13353-014-0266-1. This article has 18 citations and is from a peer-reviewed journal.